WebValidation of the German patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE™). Hagelstein V, Ortland I, Wilmer A, Mitchell SA ... Comparison of the NCI-CTCAE version 4.0 and version 3.0 in assessing chemoradiation-induced oral mucositis for locally advanced nasopharyngeal carcinoma. WebMar 25, 2024 · The Common Terminology Criteria for Adverse Events (CTCAE) was utilized by nurses and physicians to assess patients’ symptomatic AEs. ... and the toxicity was graded according to CTCAE version 5 ...
Common terminology criteria for adverse events - UpToDate
WebFeb 21, 2024 · For CRS, they include (1) consensus-based score by Lee et al (referred to herein as Lee), 6 used in the ZUMA-1 trial 1 ; (2) University of Pennsylvania’s score (referred herein to as Penn), 7 used in the JULIET and ELIANA trials 2,3 ; (3) National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE), … WebAug 30, 2024 · CTCAE stands for Common Terminology Criteria for Adverse Events; these criteria are also called "common toxicity criteria." In CTCAE, an adverse event (AE) is defined as any abnormal clinical finding temporally associated with the use of a therapy for cancer; causality is not required. These criteria are used for the management of … citizens bank st. louis
Mucositis Oral, CTCAE (Concept Id: C4552635) - National Center …
WebJun 14, 2010 · An updated version (4.03) is now in use as of June 14, 2010. The ManageCRC Advisory Panel will reference CTCAE v 4.03 for future references to adverse event grading with the exception of dose modifications that are based on earlier versions. Information cited in ManageCRC webpages will reference the CTCAE version used as a … WebApr 19, 2024 · Common Terminology Criteria for Adverse Events (CTCAE) is widely accepted throughout the oncology community as the standard classification and severity … WebTo compare the role of CTCAE version 4.0 (v4.0) and version 3.0 (v3.0) in assessing chemoradiation-induced oral mucositis (OM) for locally advanced nasopharyngeal carcinoma (LA-NPC). Patients with LA-NPC were recruited into the study. All eligible participants received docetaxel and cisplatin-based induction chemotherapy followed by … dickey health wellness center tampa